Logic Bio NASDAQ:LOGC LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a new approach to precise gene insertion that harnesses a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's cutting-edge sAAVy™ capsid development platform is designed to support development of treatments in a broad range of indications and tissues. The company is based in Lexington, MA.

Location: 65 Hayden Ave, 2Nd Floor, Massachusetts, 02421, US | Website: www.logicbio.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing